Full Press Release Details
Fort Lauderdale, FL - April 24, 2025
- SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII), a developer
of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today
announced that the Company's common stock has been approved for listing on The Nasdaq Capital Market ("Nasdaq").
Trading on Nasdaq is expected to commence on April 25, 2025, and the Company's shares will continue to be listed under the ticker
Dr. Sudhir Srivastava, Chairman of the Board and
Chief Executive Officer of SS Innovations, commented, "Uplisting to Nasdaq marks an exciting milestone for SS Innovations and reflects
our team's achievements in building a world-class robotic surgery technology platform that is designed to offer top-tier quality,
safety, efficiency and affordability, enabling cutting-edge robotic surgical procedures for a wider range of patients globally.
"The timing of our uplisting coincides with
the beginning of our global expansion beyond India - into Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka and Ukraine
- and our planned strategic entry into Europe and the United States. We are pursuing EU CE Mark and U.S. FDA approval for our SSi
Mantra surgical robotic system, which we anticipate in late 2025 and early 2026, respectively. We believe that the Nasdaq uplisting will
enhance market awareness of our growth story, improve transparency, expand our audience of potential investors, and ultimately increase
Dr. Srivastava also highlighted the Company's
recent achievements in advancing its clinically validated, patented surgical robotic system, the "SSi Mantra," including:
About SS Innovations
SS Innovations International, Inc. (OTC: SSII)
develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a
larger segment of the global population. The Company's product range includes its proprietary "SSi Mantra" surgical
robotic system and its comprehensive suite of "SSi Mudra" surgical instruments, which support a variety of surgical procedures
including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its
technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company's website at ssinnovations.com
or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra Surgical Robotic System is a user-friendly,
modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon
command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of
the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the
table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over
40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has
been clinically validated in India in more than 100 different types of surgical procedures.
Forward Looking Statements
This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words "anticipate," "assume," "believe," "estimate," "expect," "will,"
"intend," "may," "plan," "project," "should," "could," "seek,"
"designed," "potential," "forecast," "target," "objective," "goal,"
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SS Innovations International's future financial performance and involve known and unknown risks, uncertainties and other
factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future
results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Devin Sullivan, Managing Director